[1] |
SHEN Lu, LIU Cuili, WANG Yi, HAO Mingqiang, WANG Yali, ZHU Huijuan, WU Chen, YANG Yang.
Precision Pharmacovigilance for Cell and Gene Therapy Products
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 633-639.
|
[2] |
TAO Xingru, DUAN Yanyan, LIU Xiaoling, LIU Yuemei, ZHANG Shengnan.
One Case of Black Hairy Tongue Caused by Doxycycline
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 696-698.
|
[3] |
WANG Jiaqing, WANG Qi, LIU Tongtong, ZHANG Dongjie, CHEN Qi, MEI Shenghui, NING Xiao.
Determination of Linezolid Concentrations in Plasma with HPLC-MS/MS Method
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 377-380.
|
[4] |
LAN Xiaoqian, GUO Wei.
Trough Steady-State Concentration/Dose Ratio and Contributors to Adverse Drug Reactions of Sulpiride
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 420-423.
|
[5] |
LUO Wen, WU Jing, HE Dake, YANG Rui.
One Case of Dermatitis Medicamentosa in a Paediatric Epilepsy Patient Caused by Lacosamide Oral Solution
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 452-455.
|
[6] |
JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian.
Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328.
|
[7] |
LIU Biqing, ZHANG Xiaotong, WANG Ke, XING Xiaoxuan, WANG Zhizhou, ZHUANG Wei, ZHANG Qingxia, ZHANG Lan, LI Xiaoling, DONG Xianzhe.
Adverse Drug Reaction in 385 Elderly Inpatients with Bacterial Pneumonia under Polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 206-210.
|
[8] |
CAO Yin, ZHOU Xuan, DAI Biao, DENG Yiyun, YAN Chunyu, SHAN Feng, XIA Qingrong, LIANG Jun.
A UPLC-MS/MS method for determination of human serum trazodone concentration and its clinical individualized medications
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 991-997.
|
[9] |
LU Zhenkai, YANG Dingquan, XIE Zhennian, WANG Lianxin, LI Yuanyuan, WANG Zhifei, CUI Xin, XIE Yanming.
Interpretation and insights from the “Guidelines for Pharmacovigilance of Topical Traditional Chinese Medicines in Clinical Applications”
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1029-1033.
|
[10] |
LIN Lu, ZHAN Luchuan, LIU Xiaoqi, LIU Ju'e, WANG Laiyou, ZENG Ying, LAI Weihua.
Establish triggers for active monitoring of digoxin adverse events based on the China hospital pharmacovigilance system
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1039-1043.
|
[11] |
ZHANG Caixia, ZHOU Yi, TAN Lu, CHEN Wenming, LIU Yang, YOU Yu.
Pharmaceutical care of pulmonary aspergillus infection secondary to sepsis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1064-1067.
|
[12] |
LIU Ting, CAO Zhongqiang, HE Wenjia, YUAN Xiuli, CHEN Zebin, LI Xuejuan.
One case of acute severe pancreatitis caused by pegaspargase and its etiology
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1075-1077.
|
[13] |
ZHANG Qian, YUN Yuan, HE Lian.
Pharmaceutical care of hyperprolactinemia in a patient induced by risperidone
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 936-938.
|
[14] |
CHAO Ying, ZHANG Xuemei, ZHANG Chengjian, WANG Bei.
One case of ureterolith combined with gallstone caused by Ceftriaxone sodium for injection in children
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 943-945.
|
[15] |
WANG Dan, DONG Duo, TIAN Chunhua.
Course of development of pharmocovigilance systems in China
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 735-740.
|